BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 2139802)

  • 1. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
    Matherly LH; Czajkowski CA; Muench SP; Psiakis JT
    Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a localized conversion of endogenous tetrahydrofolate cofactors to dihydrofolate as an important element in antifolate action in murine leukemia cells.
    Matherly LH; Muench SP
    Biochem Pharmacol; 1990 Jun; 39(12):2005-14. PubMed ID: 2141258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells.
    Bunni M; Doig MT; Donato H; Kesavan V; Priest DG
    Cancer Res; 1988 Jun; 48(12):3398-404. PubMed ID: 3370638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.
    Duch DS; Banks S; Dev IK; Dickerson SH; Ferone R; Heath LS; Humphreys J; Knick V; Pendergast W; Singer S
    Cancer Res; 1993 Feb; 53(4):810-8. PubMed ID: 8428362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo.
    Priest DG; Bunni M; Sirotnak FM
    Cancer Res; 1989 Aug; 49(15):4204-9. PubMed ID: 2743307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
    Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
    Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
    Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
    Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmentation of intracellular folates. Failure to interconvert tetrahydrofolate cofactors to dihydrofolate in mitochondria of L1210 leukemia cells treated with trimetrexate.
    Trent DF; Seither RL; Goldman ID
    Biochem Pharmacol; 1991 Aug; 42(5):1015-9. PubMed ID: 1831361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
    Keyomarsi K; Moran RG
    Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-pool interconversions and inhibition of biosynthetic processes after exposure of L1210 leukemia cells to antifolates. Experimental and network thermodynamic analyses of the role of dihydrofolate polyglutamylates in antifolate action in cells.
    Seither RL; Trent DF; Mikulecky DC; Rape TJ; Goldman ID
    J Biol Chem; 1989 Oct; 264(29):17016-23. PubMed ID: 2529254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a folate binding protein in L1210 cells grown in low folate medium.
    Jansen G; Kathmann I; Rademaker BC; Braakhuis BJ; Westerhof GR; Rijksen G; Schornagel JH
    Cancer Res; 1989 Apr; 49(8):1959-63. PubMed ID: 2702638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular metabolism of 5-formyl tetrahydrofolate in human breast and colon cell lines.
    Boarman DM; Allegra CJ
    Cancer Res; 1992 Jan; 52(1):36-44. PubMed ID: 1370075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells.
    Rhee MS; Coward JK; Galivan J
    Mol Pharmacol; 1992 Nov; 42(5):909-16. PubMed ID: 1435754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects on 4-aminoantifolates on 5-formyltetrahydrofolate metabolism in L1210 cells. A biochemical basis of the selectivity of leucovorin rescue.
    Matherly LH; Barlowe CK; Phillips VM; Goldman ID
    J Biol Chem; 1987 Jan; 262(2):710-7. PubMed ID: 2948949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
    Davis ST; Berger SH
    Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
    Fry DW; Besserer JA; Boritzki TJ
    Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.